DK1194575T4 - Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf - Google Patents
Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling herafInfo
- Publication number
- DK1194575T4 DK1194575T4 DK00942494T DK00942494T DK1194575T4 DK 1194575 T4 DK1194575 T4 DK 1194575T4 DK 00942494 T DK00942494 T DK 00942494T DK 00942494 T DK00942494 T DK 00942494T DK 1194575 T4 DK1194575 T4 DK 1194575T4
- Authority
- DK
- Denmark
- Prior art keywords
- csf
- stimulating factor
- colony stimulating
- modified
- human granulocyte
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990027418A KR100356140B1 (ko) | 1999-07-08 | 1999-07-08 | 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법 |
PCT/KR2000/000733 WO2001004329A1 (fr) | 1999-07-08 | 2000-07-07 | Facteur stimulant les colonies de granulocytes humain modifie et son procede d'elaboration |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1194575T3 DK1194575T3 (da) | 2005-10-17 |
DK1194575T4 true DK1194575T4 (da) | 2009-12-07 |
Family
ID=36129291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00942494T DK1194575T4 (da) | 1999-07-08 | 2000-07-07 | Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040224393A1 (fr) |
EP (1) | EP1194575B2 (fr) |
JP (1) | JP2003504069A (fr) |
KR (1) | KR100356140B1 (fr) |
CN (1) | CN1195859C (fr) |
AT (1) | ATE299187T1 (fr) |
AU (1) | AU757147C (fr) |
BR (2) | BR0012265A (fr) |
CA (1) | CA2378543C (fr) |
DE (1) | DE60021188T3 (fr) |
DK (1) | DK1194575T4 (fr) |
ES (1) | ES2243275T5 (fr) |
NZ (1) | NZ516476A (fr) |
PT (1) | PT1194575E (fr) |
RU (1) | RU2232772C2 (fr) |
WO (1) | WO2001004329A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6831158B2 (en) | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
AU2002325819B2 (en) | 2001-07-11 | 2008-06-19 | Maxygen, Inc. | G-CSF Conjugates |
EP1539960B1 (fr) * | 2002-09-09 | 2010-04-28 | Hanall Pharmaceutical Co., Ltd. | Polypeptides modifiés d'interferon alpha résistant aux protéases |
US8338373B2 (en) * | 2003-10-24 | 2012-12-25 | Nora Therapeutics, Inc. | Method for reducing the risk of spontaneous abortion in a human female subject |
US20090226397A1 (en) | 2003-10-24 | 2009-09-10 | Nora Therapeutics, Inc. | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
DK2198876T3 (da) * | 2003-10-24 | 2013-03-11 | Nora Therapeutics Inc | Fremgangsmåde til nedsættelse af sandsynligheden for implantationssvigt i et individ |
CA2607844C (fr) | 2005-06-01 | 2012-07-10 | Maxygen Holdings Ltd. | Polypeptides g-csf pegyles et procedes de production correspondants |
DE102005033250A1 (de) | 2005-07-15 | 2007-01-18 | Bioceuticals Arzneimittel Ag | Verfahren zur Reinigung von G-CSF |
EP2274325A4 (fr) * | 2008-05-13 | 2011-05-25 | Nora Therapeutics Inc | Analogue du g-csf humain et ses procédés de fabrication et d'utilisation |
KR101340710B1 (ko) | 2010-01-19 | 2013-12-12 | 한미사이언스 주식회사 | 지속형 과립구 콜로니 자극인자 결합체의 액상 제제 |
TWI600759B (zh) * | 2010-04-02 | 2017-10-01 | 可娜公司 | 藉由抑制群落刺激因子3(csf3)之天然反義轉錄物以治療csf3相關疾病 |
KR101831300B1 (ko) * | 2010-10-29 | 2018-02-23 | 한미사이언스 주식회사 | 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법 |
RU2467764C2 (ru) * | 2011-01-12 | 2012-11-27 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения больных аутоиммунной хронической крапивницей с использованием внутривенного введения препарата "габриглобин" |
WO2016013725A1 (fr) * | 2014-07-23 | 2016-01-28 | 주식회사 이큐스앤자루 | Composition pharmaceutique contenant, comme principe actif, une protéine mutante du facteur stimulant les colonies de granulocytes ou la protéine de fusion de transferrine correspondante |
KR101623906B1 (ko) | 2014-07-23 | 2016-05-24 | 주식회사 이큐스앤자루 | 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물 |
WO2018143729A1 (fr) | 2017-02-03 | 2018-08-09 | 한미약품 주식회사 | Conjugué de substance bioactive ayant une durabilité améliorée et son utilisation |
US11684655B2 (en) | 2019-05-31 | 2023-06-27 | Spectrum Pharmaceuticals, Inc. | Methods of treating neutorpenia using G-CSF protein complex |
KR102375269B1 (ko) * | 2021-01-27 | 2022-03-17 | 한미약품 주식회사 | 단백질 액상 제제 및 이의 제조방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
JPH01500483A (ja) * | 1986-08-11 | 1989-02-23 | シタス コーポレイション | G‐csf及びそのミューテインの発現 |
US5362853A (en) * | 1986-12-23 | 1994-11-08 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
US5681720A (en) | 1986-12-23 | 1997-10-28 | Kyowa Hakko Co., Ltd. | DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide |
JPH02104598A (ja) | 1988-04-12 | 1990-04-17 | Kirin Amgen Inc | ヒト顆粒球コロニー刺激因子ポリペプチド誘導体 |
NZ236819A (en) | 1990-02-03 | 1993-07-27 | Max Planck Gesellschaft | Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions |
GB9107846D0 (en) | 1990-04-30 | 1991-05-29 | Ici Plc | Polypeptides |
EP0626448A3 (fr) | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Procédé de la préparation et de purification d'interféron-alpha |
US6476198B1 (en) | 1993-07-13 | 2002-11-05 | The Scripps Research Institute | Multispecific and multivalent antigen-binding polypeptide molecules |
US5451660A (en) * | 1993-12-13 | 1995-09-19 | Genentech, Inc. | Method for purifying polypeptides |
WO1996013599A1 (fr) * | 1994-11-01 | 1996-05-09 | Winfried Wels | Systeme de transfert de l'acide nucleique |
US6100070A (en) | 1995-10-05 | 2000-08-08 | G. D. Searle & Co. | G-CSF receptor agonists |
US7306931B2 (en) * | 2000-05-16 | 2007-12-11 | Bolder Biotechnology, Inc. | Method for refolding proteins containing free cysteine residues |
KR100316347B1 (ko) * | 1998-09-15 | 2002-08-27 | 한미약품(주) | 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법 |
-
1999
- 1999-07-08 KR KR1019990027418A patent/KR100356140B1/ko not_active IP Right Cessation
-
2000
- 2000-07-07 WO PCT/KR2000/000733 patent/WO2001004329A1/fr active IP Right Grant
- 2000-07-07 AT AT00942494T patent/ATE299187T1/de active
- 2000-07-07 ES ES00942494T patent/ES2243275T5/es not_active Expired - Lifetime
- 2000-07-07 AU AU57106/00A patent/AU757147C/en not_active Expired
- 2000-07-07 JP JP2001509533A patent/JP2003504069A/ja active Pending
- 2000-07-07 CA CA2378543A patent/CA2378543C/fr not_active Expired - Lifetime
- 2000-07-07 BR BR0012265-3A patent/BR0012265A/pt not_active IP Right Cessation
- 2000-07-07 EP EP00942494A patent/EP1194575B2/fr not_active Expired - Lifetime
- 2000-07-07 DE DE60021188T patent/DE60021188T3/de not_active Expired - Lifetime
- 2000-07-07 BR BRPI0012265A patent/BRPI0012265B8/pt unknown
- 2000-07-07 RU RU2002103159/13A patent/RU2232772C2/ru active
- 2000-07-07 NZ NZ516476A patent/NZ516476A/en not_active IP Right Cessation
- 2000-07-07 CN CNB008100942A patent/CN1195859C/zh not_active Expired - Lifetime
- 2000-07-07 PT PT00942494T patent/PT1194575E/pt unknown
- 2000-07-07 DK DK00942494T patent/DK1194575T4/da active
-
2002
- 2002-01-09 US US10/031,123 patent/US20040224393A1/en not_active Abandoned
-
2007
- 2007-10-19 US US11/975,541 patent/US7704709B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE299187T1 (de) | 2005-07-15 |
DE60021188T3 (de) | 2010-04-01 |
US20040224393A1 (en) | 2004-11-11 |
CN1195859C (zh) | 2005-04-06 |
KR100356140B1 (ko) | 2002-10-19 |
BRPI0012265B1 (pt) | 2018-11-21 |
AU757147B2 (en) | 2003-02-06 |
NZ516476A (en) | 2003-09-26 |
ES2243275T3 (es) | 2005-12-01 |
DK1194575T3 (da) | 2005-10-17 |
JP2003504069A (ja) | 2003-02-04 |
WO2001004329A1 (fr) | 2001-01-18 |
DE60021188D1 (de) | 2005-08-11 |
PT1194575E (pt) | 2005-10-31 |
AU757147C (en) | 2005-03-03 |
EP1194575A4 (fr) | 2002-10-24 |
ES2243275T5 (es) | 2009-12-02 |
EP1194575B1 (fr) | 2005-07-06 |
EP1194575B2 (fr) | 2009-08-26 |
US7704709B2 (en) | 2010-04-27 |
CA2378543C (fr) | 2010-05-18 |
CN1360636A (zh) | 2002-07-24 |
CA2378543A1 (fr) | 2001-01-18 |
AU5710600A (en) | 2001-01-30 |
RU2232772C2 (ru) | 2004-07-20 |
DE60021188T2 (de) | 2006-04-27 |
BRPI0012265B8 (pt) | 2021-05-25 |
KR20010009171A (ko) | 2001-02-05 |
US20080064066A1 (en) | 2008-03-13 |
BR0012265A (pt) | 2002-03-12 |
EP1194575A1 (fr) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1194575T3 (da) | Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf | |
PL331351A1 (en) | Novel strains of escherichia coli, methods of obtaining them and their application in l-treonin production fermentation processes | |
IL145288A (en) | Isolated cytokine zalpha11 ligand polypeptide and uses thereof | |
DE69739715D1 (de) | Herstellungsverfahren von 1,3-propandiol durch rekombinante organismen | |
NZ595500A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
AU9096001A (en) | G-csf analog compositions and methods | |
ATE77104T1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
DE69929805D1 (de) | Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert | |
DE59104720D1 (de) | Antifungisches polypeptid, verfahren zu seiner herstellung. | |
DE60228213D1 (de) | Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae in den das frur-gen deletiert worden ist | |
DE3683267D1 (de) | Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung. | |
SU1720493A3 (ru) | Способ получени штамма SтRертососсUS SaNGUIS, способного секретировать @ -1,3-глюкан-3-глюканогидролазу | |
ATE246247T1 (de) | Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
HRP960078B1 (en) | Dna sequence coding for a protein of a. thaliana having a delta-5, 7 sterol, delta- 7 reductase activity, delta-7-red protein, production process, strains of transformed yeasts, uses | |
DE69738079D1 (de) | Systeme zur massenherstellung von proteinen oder peptiden durch mikroorganismen der gattung humicola | |
WO2001096527A3 (fr) | Peptides à activité physiologique | |
ATE334195T1 (de) | Proteine mit zellulase-aktivitäten und prozess für ihre herstellung | |
CN110396533B (zh) | 具有噬菌体抗性的大肠杆菌菌株、筛选方法、重组工程菌表达重组蛋白的制备方法 | |
WO2017181920A1 (fr) | Procédé de préparation d'un facteur de croissance hématopoïétique g-csf humain recombiné | |
MX9605082A (es) | Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano. | |
Mak et al. | Formulation and optimization of two culture media for the production of tumour necrosis factor‐β in Escherichia coli | |
IL158244A0 (en) | Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same | |
WO2003029457A1 (fr) | Procede de production d'acide amine | |
FR2785291B1 (fr) | Procede de production in vivo de proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels | |
DE60033823D1 (de) | Rekombinante mikroorganismen |